Skip to main content

and
  1. Article

    Allogeneic Hematopoietic Stem Cell Transplantation Activity in Inborn Errors of Immunity in Russian Federation

    Allogeneic hematopoietic stem cell transplantation (HSCT) is an established therapy for many inborn errors of immunity (IEI). The indications for HSCT have expanded over the last decade. The study aimed to col...

    Alexandra Laberko, Anna Mukhinа, Elena Machneva in Journal of Clinical Immunology (2023)

  2. Article

    Open Access

    Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML

    Allogeneic hematopoietic stem-cell transplantation (HSCT) remains the only curative option for patients with advanced chronic myeloid leukemia (CML). However, outcome is dismal and of short follow-up. The obje...

    Christian Niederwieser, Elena Morozova, Ludmila Zubarovskaya in Bone Marrow Transplantation (2021)

  3. Article

    Open Access

    Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

    Allogeneic hematopoietic cell transplantation (allo-HCT) using a mismatched unrelated donor (MMUD) and cord blood transplantation (CBT) are valid alternatives for patients without a fully human leukocyte antig...

    Bhagirathbhai Dholaria, Myriam Labopin, Jaime Sanz in Journal of Hematology & Oncology (2021)